GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » Debt-to-EBITDA

MyndTec (XCNQ:MYTC) Debt-to-EBITDA : -0.42 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MyndTec Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MyndTec's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$0.44 Mil. MyndTec's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$0.02 Mil. MyndTec's annualized EBITDA for the quarter that ended in Sep. 2024 was C$-1.12 Mil. MyndTec's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was -0.42.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MyndTec's Debt-to-EBITDA or its related term are showing as below:

XCNQ:MYTC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.49   Med: -0.59   Max: -0.29
Current: -0.39

During the past 4 years, the highest Debt-to-EBITDA Ratio of MyndTec was -0.29. The lowest was -1.49. And the median was -0.59.

XCNQ:MYTC's Debt-to-EBITDA is ranked worse than
100% of 431 companies
in the Medical Devices & Instruments industry
Industry Median: 1.54 vs XCNQ:MYTC: -0.39

MyndTec Debt-to-EBITDA Historical Data

The historical data trend for MyndTec's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyndTec Debt-to-EBITDA Chart

MyndTec Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-1.49 -0.79 -0.39 -0.29

MyndTec Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -0.36 -0.41 -0.36 -0.42

Competitive Comparison of MyndTec's Debt-to-EBITDA

For the Medical Devices subindustry, MyndTec's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MyndTec's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MyndTec's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MyndTec's Debt-to-EBITDA falls into.



MyndTec Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MyndTec's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.456 + 0) / -1.579
=-0.29

MyndTec's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.443 + 0.021) / -1.116
=-0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


MyndTec  (XCNQ:MYTC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


MyndTec Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MyndTec's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MyndTec Business Description

Traded in Other Exchanges
N/A
Address
1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9
MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec Headlines

No Headlines